An orphan drug is a pharmaceutical agent developed to treat rare special medical conditions. These drugs are called “orphan” because under normal market conditions the pharmaceutical industry has little interest in developing and marketing products intended for only a small number of patients. More than 770 medicines have been approved by the U.S. Food and Drug Administration (FDA) since enactment of the Orphan Drug Act in 1983. We have sources to the following rare products and can arrange shipment. Lead time for orphan drugs varies from product to product.
Eftrenonacog alfa
Avatrombopag
Emapalumab
Anakira
Nitisinone
Akynze
Palonosetron
Sodium Phenylacetate & Sodium benzoate
Palifermin
Methyl naltrexone bromide
Trientine hcl
Volanesorsen & Tetra benazine